Clover Health Investments Price to Book Ratio 2020-2024 | CLOV

Historical price to book ratio values for Clover Health Investments (CLOV) over the last 10 years. The current price to book ratio for Clover Health Investments as of November 22, 2024 is 4.91.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Clover Health Investments Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-21 3.36 4.91
2024-09-30 2.82 $0.68 4.12
2024-06-30 1.23 $0.65 1.88
2024-03-31 0.79 $0.59 1.35
2023-12-31 0.95 $0.59 1.63
2023-09-30 1.08 $0.66 1.63
2023-06-30 0.90 $0.68 1.31
2023-03-31 0.85 $0.67 1.26
2022-12-31 0.93 $0.75 1.25
2022-09-30 1.70 $0.82 2.07
2022-06-30 2.14 $0.89 2.39
2021-12-31 3.72 $1.15 3.25
2021-09-30 7.39 $0.98 7.54
2021-06-30 13.32 $0.77 17.27
2021-03-31 7.56 $1.44 5.24
2020-12-31 16.77 $-6.87 -2.44
2022-03-31 3.55 $1.03 3.43
2020-09-30 12.46 $0.21 60.37
2020-06-30 11.18 $0.21 53.65
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.684B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.263B 0.00
Inspire Medical Systems (INSP) United States $5.580B 174.01
Hims & Hers Health (HIMS) United States $5.276B 134.17
Enovis (ENOV) United States $2.580B 17.49
Privia Health (PRVA) United States $2.530B 210.80
IRhythm Technologies (IRTC) United States $2.313B 0.00
Azenta (AZTA) United States $2.227B 111.05
Omnicell (OMCL) United States $2.043B 66.83
10x Genomics (TXG) United States $1.609B 0.00
Schrodinger (SDGR) United States $1.484B 0.00
Phreesia (PHR) United States $1.098B 0.00
Butterfly Network (BFLY) United States $0.701B 0.00
Standard BioTools (LAB) United States $0.603B 0.00
Talkspace (TALK) United States $0.559B 0.00
Fulgent Genetics (FLGT) United States $0.518B 0.00
Definitive Healthcare (DH) United States $0.491B 85.00
Health Catalyst (HCAT) United States $0.466B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
TruBridge (TBRG) United States $0.239B 69.61
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
American Well (AMWL) United States $0.123B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.075B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Zepp Health (ZEPP) China $0.038B 0.00
Movano (MOVE) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.010B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00